Actively Recruiting

Phase Not Applicable
Age: 13Years - 19Years
FEMALE
Healthy Volunteers
ID07576231

Comparative Effects of Sacral Release Technique and Lumbar Mobilization in Pain, Symptoms Severity and Quality of Life in Primary Dysmenorrhea

Led by Riphah International University · Updated on 2026-05-08

46

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of two manual therapy techniques, sacral release technique and lumbar mobilization, on pain, symptom severity, and quality of life in adolescent females with primary dysmenorrhea. This randomized clinical trial involves 46 females aged 13 to 19 years diagnosed with primary dysmenorrhea. The study aims to compare how each technique impacts these outcomes over a period of six weeks. Participants are randomly assigned to one of two groups. Group A receives the sacral release technique, where gentle, sustained holds lasting 3 to 5 minutes are applied 2 to 3 times per session, with sessions lasting 15 to 20 minutes, three times per week for two consecutive menstrual cycles. Group B undergoes lumbar mobilization treatments three times per menstrual cycle over the same six-week period. Both interventions are provided over two menstrual cycles. During the study, pain intensity will be measured using the Numerical Pain Rating Scale, symptom severity will be assessed with a menstrual symptom questionnaire, and quality of life will be evaluated using the EuroQOL-5 Dimension Questionnaire. These assessments occur at the end of the six-week intervention period. Data will be analyzed to determine statistical significance. Participants will attend sessions and be monitored for changes in pain, symptoms, and quality of life throughout the study.

CONDITIONS

Brief Title

Effects of Sacral Release Technique and Lumbar Mobilization in Primary Dysmenorrhea.

Who Can Participate

Age: 13Years - 19Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Female aged 13 to 19 years
  • Unmarried female
  • Diagnosed with primary dysmenorrhea through WaLIDD Score
  • Regular menstrual cycles (21-35 days)
  • Pain score greater than 4 on the Numerical Pain Rating Scale during menstruation
Not Eligible

You will not qualify if you...

  • Pelvic inflammatory disease
  • Obesity
  • Polycystic Ovary Syndrome (PCOS)
  • Spinal deformity
  • Lumbar radiculopathy
  • Heavy menstrual bleeding (menorrhagia)
  • Irregular menstrual cycles
  • Spine trauma and coccyx pain
  • History of pelvic or spinal surgery
  • Currently on hormonal therapy
  • Receiving other ongoing physiotherapy for dysmenorrhea

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 6 weeks

Participants receive either Sacral Release Technique or Lumbar Mobilization therapy to relieve pain and improve symptoms of primary dysmenorrhea.

3 sessions per menstrual cycle for two consecutive cycles

Trial Site Locations

Total: 1 location

1

Ittefaq Hospital

Lahore, Punjab Province, Pakistan, 6400

Actively Recruiting

Loading map...

Research Team

I

imran G amjad

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Menarche, pubertal timing and the brain: female-specific patterns of brain maturation beyond age-related development.

Nina Gottschewsky, Dominik Kraft, Tobias Kaufmann

https://pubmed.ncbi.nlm.nih.gov/38532493